Translational activators of glutamate transporter 1 (GLT1), such as ceftriaxone and LDN/OSU-0212320 have significant protective effects in animal models of amyotrophic lateral sclerosis and epilepsy [81, 82]. Here, SLC1A2 is linked to epilepsy.